TGFB1 and neoplasm: These findings are consistent with studies of human NSCLC showing that soluble tumor-derived factors suppress GrB expression in infiltrating CD8+ T cells (55), with TGF-β1 specifically shown to repress GrB transcription and cytotoxic function (56).